Medical and pharmacy communities in harsh disputes on topical drug reclassification.

Published: 2001-05-24 06:58:00

Updated: 2001-05-24 06:58:00

The government plans called for the issue on drug reclassifications to be completed until the end of coming June, showing, unfortunately, a tensive confrontation especially on the topical drugs between medical and pharmacy communities.

Such a sharp confrontation has been presumed since April ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK